Dimethylformamide dimethyl acetal → HCID 22605463, compound
Reaction equation
[Cl:1][C:2]1[CH:3]=[C:4]([CH:8]=[CH:9][C:10]=1[C:11]([N:13]1[C:19]2[CH:20]=[CH:21][CH:22]=[CH:23][C:18]=2[CH2:17][N:16]2[CH:24]=[CH:25][CH:26]=[C:15]2[CH2:14]1)=[O:12])[C:5]([NH2:7])=[O:6].CO[CH:29](OC)[N:30]([CH3:32])[CH3:31]>>[CH3:29][N:30]([CH:32]=[N:7][C:5](=[O:6])[C:4]1[CH:8]=[CH:9][C:10]([C:11]([N:13]2[C:19]3[CH:20]=[CH:21][CH:22]=[CH:23][C:18]=3[CH2:17][N:16]3[CH:24]=[CH:25][CH:26]=[C:15]3[CH2:14]2)=[O:12])=[C:2]([Cl:1])[CH:3]=1)[CH3:31]Participants
3
Procedure
The title compound was prepared in the same manner as described in Example 80, employing 3-chloro-4-(5H,11H-pyrrolo[2,1-c][1,4]benzodiazepine-10-carbonyl)-benzamide (1.83 g) and dimethylformamide dimethylacetal (5.3 ml), MS (EI), m/z::420 (M)+.
Sources & evidence
- ORD record
- ord-04528a640af44306ac77497e943dfa70
- Source dataset
- uspto-grants-2004_12
- Patent number
- US06831079B1
Reaction notes
Loading…